Document Detail


Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
MedLine Citation:
PMID:  7272934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A pediatric patient is reported who experienced fatal progressive pulmonary fibrosis as a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy. The patient received a cumulative dosage of 1.29 g (1.72 g/m2) over a two-year period as adjuvant therapy for a medulloblastoma. Two and one-half years after cessation of therapy, cough, tachypnea and fatigue were noted. Progressive pulmonary insufficiency developed. Pulmonary pathologic findings included interstitial fibrosis and alveolar dysplasia. Other cases of BCNU pulmonary toxicity are cited from the medical literature.
Authors:
B R Ryan; T R Walters
Related Documents :
477424 - Variability in interpretation of pulmonary function tests.
20019344 - Pulmonary alveolar proteinosis in workers at an indium processing facility.
7333234 - Review of pulmonary effects of poly(vinyl chloride) and vinyl chloride exposure.
25349724 - A preliminary observation of weight loss following left gastric artery embolization in ...
3567364 - Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in h...
22064974 - Concordance rates of doppler ultrasound and ct angiography in the grading of carotid ar...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cancer     Volume:  48     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1981 Aug 
Date Detail:
Created Date:  1981-11-18     Completed Date:  1981-11-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  909-11     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Neoplasms / drug therapy
Carmustine / adverse effects*
Child, Preschool
Humans
Medulloblastoma / drug therapy
Pulmonary Fibrosis / chemically induced*
Risk
Chemical
Reg. No./Substance:
154-93-8/Carmustine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Corticosteroids for elderly patients with breast cancer.
Next Document:  Influence of topical and systemic retinoids on basal cell carcinoma cell membranes.